Effects of Inspiratory Muscle Training in Patients With Sarcoidosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcoidosis
- Sponsor
- Gazi University
- Enrollment
- 30
- Primary Endpoint
- Maximum inspiratory and expiratory muscle strength (MIP, MEP)
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
Respiratory muscle weakness results with decreased exercise capacity, worse fatigue, dyspnea and quality of life in patients with sarcoidosis. However, no study investigated the effects of inspiratory muscle training (IMT), therefore effects of IMT on outcomes in patients with sarcoidosis were investigated.
Detailed Description
Patients were diagnosed with sarcoidosis according to the criteria of the latest American Thoracic Society (ATS)/European Respiratory Society (ERS)/World Association of Sarcoidosis and Other Granulomatous (WASOG) Disorders statement on sarcoidosis. Primary outcome measurement was respiratory muscle strength, secondary outcomes were, exercise capacity quality of life, fatigue and depression.
Investigators
Meral Boşnak Güçlü
Assoc. Prof.
Gazi University
Eligibility Criteria
Inclusion Criteria
- •Clinically stable
- •Under standard medication
- •Stage I and IV
- •No change in medications over three months
Exclusion Criteria
- •Cognitive disorders
- •Current corticosteroid use
- •Having co-morbidity to prevent performing IMT
- •Acute infection
- •Orthopedic and neurological problems
Outcomes
Primary Outcomes
Maximum inspiratory and expiratory muscle strength (MIP, MEP)
Time Frame: 6 weeks
Mouth pressure device
Secondary Outcomes
- Exercise Capacity(6 weeks)
- Pulmonary function and diffusing capacity(6 weeks)
- Fatigue(6 weeks)
- Dyspnea(6 weeks)
- Maximal Exercise Capacity(6 weeks)
- Peripheral muscle strength(6 weeks)
- Quality of life(6 weeks)
- Depression(6 weeks)